Blog

Congratulations to Michael Dilworth and Ben Lehberger on their selection to The Best Lawyers in America® 2027 for Intellectual Property Law. The recognition reflects their dedication to helping clients navigate complex IP challenges with practical, business-focused counsel, while Mike’s recent IAM Strategy 300 recognition further highlights his leadership in IP strategy.

Dr. Anthony Sabatelli, Partner and Chair of Dilworth IP’s Biotech and Pharmaceutical IP practice group, has been appointed to serve on CURE’s Board of Directors. CURE (Connecticut United for Research Excellence) serves as the bioscience cluster for the state, and is a diverse community of small and large life and healthcare sciences companies, ranging in scope from therapeutics, to healthcare technology, to medical devices. Universities, government agencies, scientists, educators, mentors, students, entrepreneurs, business experts, service providers and investors further form the breadth of the network. Regarding his appointment, Dr. Sabatelli said that “I am honored to serve CURE in this capacity because it is an important advocate for the state’s bioscience community.”

Dr. Anthony Sabatelli and Dr. Jonathan Schuchardt, both Partners at Dilworth IP, will be presenting at the 250th American Chemical Society National Meeting and Exposition in Boston this Thursday, August 20th. The theme of this year’s meeting is Innovation: from Discovery to Application and both presentations will be part of the ACS’s Chemistry and the Law (CHAL) Division’s slate of talks.

Jessica Miles, Technology Specialist at Dilworth IP and PhD candidate at Yale University, is presenting at the Boston Bacterial Meeting this Thursday, June 18 and Friday, June 19, 2015 at the Harvard University Science Center. The title of her poster is “Using Insertion Sequencing (INSeq) to identify genetic determinants of gut colonization.”

Dilworth IP’s Biotech and Pharmaceutical Practice Group has been joined by Jessica Miles, a Technology Specialist from Yale University’s Office of Cooperative Research (OCR). Ms. Miles is currently a Ph.D. candidate in Microbiology at Yale where her research has focused on identifying genetic mediators of interactions between the microbiome and infectious bacteria. She is also well-versed in biochemistry, molecular biology, and cell biology, having had over 10 years of research experience in five different academic laboratories. Jessica’s work at OCR involved a variety of technology areas including miRNA therapy, regenerative medicine, and immunotherapy. There, she evaluated early stage research and reviewed prior art to advance intellectual property with commercial potential. She also identified biotechnology and pharmaceutical companies for licensing opportunities and composed marketing material to promote technology licensing and research sponsorship.

Michael Dilworth and Dr. Anthony Sabatelli of Dilworth IP will be attending the 2015 BIO National Convention in Philadelphia (BIO 2015) June 15th-19th. They will be joined by several other organizations and businesses from Connecticut’s life science community showcasing the state’s leadership in the biosciences. The Firm is one of several sponsors of the Connecticut Booth along with Yale University, the University of Connecticut, The Jackson Laboratory, the Town of Branford, CT, and CURE (CT United for Research Excellence).

Cambria Alpha-Cobb, Ph.D., Technology Specialist at Dilworth IP, is presenting at a Career Development Workshop series at UConn Health this Thursday May 28, 2015, at 1:30 pm. The title of the presentation is How to stay close to science when you get pulled away from the bench: An introduction to a career in IP law.

The workshop series is designed to expose graduate students and postdoctoral scholars to various career opportunities in the life sciences. Dr. Alpha-Cobb will present on her career path in IP law, emphasizing the skill sets required at various stages of her career, including past, current and future positions!

Dilworth IP will be hosting an afternoon seminar on Wednesday, April 29th at 1:30pm at the Cambridge Innovation Center (CIC), 5th Floor 1 Broadway, Cambridge, MA. Dr. Anthony Sabatelli and Dr. Cambria Alpha-Cobb will address many common questions about the patent process. The talk will be geared toward inventors and entrepreneurs alike.

Patent Basics for Entrepreneurs: Ever wondered which of your ideas were patentable? What is the first step towards applying for a patent? Why do patents even exist? During this seminar we discuss the flow between inventions and patents, how a patent works, the time line to getting a patent, in addition to highlighting some examples and recent trends from the US patent and trademark office. Following will be a question and answer session to address further questions on basic patent law! Light snacks to ward off the post-lunch slump.

Cambria Alpha-Cobb, Ph.D., Technology Specialist at Dilworth IP is moderating a panel on April 22nd entitled Non-traditional Careers in Bio presented by Women in Bio of Greater Boston. The event description from the website reads:

Women In Bio is an organization of professionals committed to promoting careers, leadership, and entrepreneurship for women in the life sciences. This event will feature a panel discussion for those interested in learning about opportunities available in the scientific community beyond the traditional academic and industrial roles. The panel will include several speakers who have taken either a non-traditional path to a career in science, or used their background in the life sciences to pursue a career of the non-academic or industry nature. These speakers will represent a variety of fields including but not limited to patent law, consulting, and practicing medicine!

Frederick Spaeth, Partner at Dilworth IP, will be presenting at the Joint Patent Practice Seminar at the Marriott Marquis in NYC on May 12th. Fred will be speaking briefly as part of a panel which will discuss the impact on patent law of recent and various Supreme Court decisions. His talk is entitled The Nautilus Decision Defines the Test for Indefiniteness: Nautilus v. Biosig Instruments.